Psoriasis in Children

Overview

Journal Psoriasis (Auckl)

Publisher Dove Medical Press

Date 2018 Feb 2

PMID 29387599

Citations 5

Authors

Roxanne Pinson

Bahman Sotoodian

Loretta Fiorillo

Affiliations

Soon will be listed here.

Abstract

The clinical presentation, disease associations, and diverse treatment modalities in overcoming the challenges of managing pediatric psoriasis have been extensively summarized in this article. An extensive literature review revealed the differences in presentation of psoriasis during infancy, childhood, and adolescence. We also summarized the latest topical, systemic, and biological modalities in treating recalcitrant psoriasis. The association of psoriasis with juvenile arthritis and obesity and the significant influence of the disease on the children's quality of life were explored. The clinical presentation of psoriasis can evolve during the child's lifespan. While many treatment modalities already exist for treating pediatric psoriasis, some of the new biologics that are approved for adult patients have not been investigated in the pediatric population and no algorithm exists for their use in this population. Large clinical studies in the future will enhance our understanding with regards to their safety and potential implications in pediatric populations.

Citing Articles

Pediatric psoriasis: Biologics and oral small molecule inhibitors in modern therapy.

Firek A, Castelo-Soccio L JAAD Rev. 2025; 3:51-56.

PMID: 39950181 PMC: 11815549. DOI: 10.1016/j.jdrv.2024.12.008.

A Rare Case of Juvenile Psoriatic Arthritis.

Dinulescu A, Prejmereanu A, Pacurar D, Neagu O, Dijmarescu I Cureus. 2024; 16(11):e72985.

PMID: 39640142 PMC: 11617492. DOI: 10.7759/cureus.72985.

Exploring comorbidity and pharmacological treatment patterns in psoriasis - a retrospective population-based cross-sectional study.

Hamgard N, Duvetorp A, Hagg A, Jerkovic Gullin S, Seifert O J Multimorb Comorb. 2023; 13:26335565231212336.

PMID: 37915465 PMC: 10617277. DOI: 10.1177/26335565231212336.

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.

Diotallevi F, Simonetti O, Rizzetto G, Molinelli E, Radi G, Offidani A Int J Mol Sci. 2022; 23(19).

PMID: 36232430 PMC: 9569815. DOI: 10.3390/ijms231911128.

Management of psoriasis in children (Review).

Branisteanu D, Georgescu S, Serban I, Pinzariu A, Boda D, Maranduca M Exp Ther Med. 2021; 22(6):1429.

PMID: 34707710 PMC: 8543441. DOI: 10.3892/etm.2021.10864.

References

Ganemo A, Wahlgren C, Svensson A . Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011; 28(4):375-9. DOI: 10.1111/j.1525-1470.2010.01292.x. View

Wright N, Piggott C, Eichenfield L . The role of biologics and other systemic agents in the treatment of pediatric psoriasis. Semin Cutan Med Surg. 2010; 29(1):20-7. DOI: 10.1016/j.sder.2010.01.003. View

Zampieron A, Buja A, Fusco M, Linder D, Bortune M, Piaserico S . Quality of life in patients with scalp psoriasis. G Ital Dermatol Venereol. 2014; 150(3):309-16. View

Steele J, Choi C, Kwong P . Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol. 2005; 53(4):713-6. DOI: 10.1016/j.jaad.2005.05.036. View

Pereira T, Vieira A, Fernandes J, Sousa-Basto A . Cyclosporin A treatment in severe childhood psoriasis. J Eur Acad Dermatol Venereol. 2006; 20(6):651-6. DOI: 10.1111/j.1468-3083.2006.01562.x. View

Pourciau C, Shwayder T . Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab. Pediatr Dermatol. 2010; 27(5):539-40. DOI: 10.1111/j.1525-1470.2010.01267.x. View

Gooderham M, Debarre J, Keddy-Grant J, Xu Z, Kurvits M, Goodfield M . Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age. Br J Dermatol. 2014; 171(6):1470-7. PMC: 4298245. DOI: 10.1111/bjd.13235. View

Marqueling A, Cordoro K . Systemic treatments for severe pediatric psoriasis: a practical approach. Dermatol Clin. 2013; 31(2):267-88. DOI: 10.1016/j.det.2012.12.005. View

Landells I, Marano C, Hsu M, Li S, Zhu Y, Eichenfield L . Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study. J Am Acad Dermatol. 2015; 73(4):594-603. DOI: 10.1016/j.jaad.2015.07.002. View

10.

van Geel M, Mul K, de Jager M, van de Kerkhof P, de Jong E, Seyger M . Systemic treatments in paediatric psoriasis: a systematic evidence-based update. J Eur Acad Dermatol Venereol. 2014; 29(3):425-37. DOI: 10.1111/jdv.12749. View

11.

Bronckers I, Paller A, van Geel M, van de Kerkhof P, Seyger M . Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Paediatr Drugs. 2015; 17(5):373-84. PMC: 4744260. DOI: 10.1007/s40272-015-0137-1. View

12.

Callen J, Jackson J . Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent. J Dermatolog Treat. 2006; 16(5-6):350-2. DOI: 10.1080/09546630500430604. View

13.

Silverberg N . Update on pediatric psoriasis. Cutis. 2015; 95(3):147-52. View

14.

Young M, Horn E, Cather J . The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients. Expert Rev Clin Immunol. 2010; 7(1):9-13. DOI: 10.1586/eci.10.92. View

15.

Amichai B . Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream. J Eur Acad Dermatol Venereol. 2004; 18(6):742-3. DOI: 10.1111/j.1468-3083.2004.01054.x. View

16.

Mansouri P, Farshi S . Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J. 2006; 12(2):7. View

17.

Kimball A, Wu E, Guerin A, Yu A, Tsaneva M, Gupta S . Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012; 67(4):651-7.e1-2. DOI: 10.1016/j.jaad.2011.11.948. View

18.

Patrizi A, Raone B, Ravaioli G . Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015; 8:511-20. PMC: 4599569. DOI: 10.2147/CCID.S87987. View

19.

Gelfand J, Weinstein R, Porter S, Neimann A, Berlin J, Margolis D . Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005; 141(12):1537-41. DOI: 10.1001/archderm.141.12.1537. View

20.

Mercy K, Kwasny M, Cordoro K, Menter A, Tom W, Korman N . Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013; 30(4):424-8. PMC: 3641153. DOI: 10.1111/pde.12072. View